Erschienen in:
30.08.2019 | Head and Neck Oncology
Clinical Significance of Gross Invasion of Strap Muscles in Patients With 1- to 4-cm-Sized Papillary Thyroid Carcinoma Undergoing Lobectomy
verfasst von:
Eyun Song, MD, Won Woong Kim, MD, Min Ji Jeon, MD, PhD, Tae-Yon Sung, MD, PhD, Dong Eun Song, MD, PhD, Tae Yong Kim, MD, PhD, Ki Wook Chung, MD, PhD, Won Bae Kim, MD, PhD, Young Kee Shong, MD, PhD, Suck Joon Hong, MD, PhD, Yu-Mi Lee, MD, PhD, Won Gu Kim, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 13/2019
Einloggen, um Zugang zu erhalten
Abstract
Background
Given the emerging evidence supporting the lack of prognostic significance of gross extrathyroidal extension invading only strap muscles (strap-gETE), this study investigated whether lobectomy is feasible for patients with strap-gETE.
Methods
A retrospective cohort study was conducted with 636 patients who had 1- to 4-cm-sized papillary thyroid carcinoma (PTC) treated with thyroid lobectomy. Patients with gross invasion of perithyroidal organs other than strap muscles or synchronous distant metastasis were excluded from the study. Disease-free survival (DFS) was compared according to the presence of strap-gETE.
Results
Strap-gETE was present in 50 patients (7.9%), with the remaining 586 patients (92.1%) showing no evidence of gETE. During the median follow-up period of 7.4 years, 6% of the patients with strap-gETE and 5.1% of the patients without gETE experienced structural persistent/recurrent disease (p = 0.99). No differences in DFS were observed between the two groups (hazard ratio [HR], 1.24; 95% confidence interval [CI], 0.38–4.08; p = 0.720). After adjustment for five major risk factors (age, gender, tumor size, multifocality, and cervical lymph node metastasis status) in the multivariate analysis, the presence of strap-gETE did not exhibit an independent role in the development of structural persistent/recurrent disease (HR 1.05; 95% CI 0.24–4.53, p = 0.950).
Conclusions
Strap-gETE did not increase the risk of structural persistent/recurrent disease for the patients who underwent lobectomy for 1- to 4-cm-sized PTC. The study data support the limited role of strap-gETE in clinical outcomes and may broaden the indications for lobectomy for patients with PTCs.